Lamisil DermGel 10 mg/g gel
| Name | Lamisil DermGel 10 mg/g gel |
|---|---|
| Former Name | Lamisil DermGel 1% gel |
| Marketing Authorisation Number | HR-H-344287404 |
| Active Substance | terbinafin |
| Composition | 1 g gela sadrži 10 mg terbinafina |
| Pharmaceutical Form | gel |
| Manufacturer | GlaxoSmithKline Consumer Healthcare GmbH & Co. KG, München, Njemačka Delpharm Huningue S.A.S., Huningue, Francuska |
| Marketing Authorisation Holder | GlaxoSmithKline Dungarvan Ltd., Knockbrack, Dungarvan, County Waterford, Irska |
| Marketing Authorisation Date | 11.12.2018 |
| MA Period of Validity | unlimited |
| Classification Number | UP/I-530-09/15-02/319 |
| Registration Number | 381-12-01/38-18-18 |
| Prescription | na recept |
| Type of prescription | neponovljivi recept |
| Distribution | u ljekarni |
| Advertising to general public | zabranjeno |
| ATC Code | D01AE15 |
| Medicinal product marketed in the Croatia | Da |
| SmPC | download |
| PL | download |
